A novel classification of tumour budding in colorectal cancer based on the presence of cytoplasmic pseudo-fragments around budding foci

被引:87
作者
Shinto, E
Mochizuki, H
Ueno, H
Matsubara, O
Jass, JR
机构
[1] McGill Univ, Dept Pathol, Montreal, PQ H3A 2B4, Canada
[2] Natl Def Med Coll, Dept Pathol 2, Tokorozawa, Saitama 359, Japan
[3] Natl Def Med Coll, Dept Surg 1, Tokorozawa, Saitama 359, Japan
关键词
colorectal cancer; cytoplasmic pseudo-fragments; invasive marker; tumour budding;
D O I
10.1111/j.1365-2559.2005.02162.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: Tumour budding is an adverse prognostic factor in colorectal cancer (CRC). We have investigated the significance of cytoplasmic fragments occurring in the immediate vicinity of tumour budding foci. Methods and results: Seventy-three CRCs with high-grade budding (> 10 budding foci in a x 20 objective field) were classified according to extent of budding (10-19 versus 20+ foci) and by the presence or absence of cytoplasmic fragments identified by immunostaining for cytokeratin. In serial sections, cytoplasmic fragments were shown to be dendritic cell processes in continuity with budding tumour cells and were renamed pseudo-fragments. Cytoplasmic pseudo-fragments, but not extent of budding, were associated with aberrant expression of beta-catenin (P = 0.045) and laminin-5 gamma 2 (P < 0.0001), and with absent peritumoral lymphocytic infiltration (P = 0.0077). Cytoplasmic pseudo-fragments had a stronger association with infiltrating growth pattern (P = 0.0014) than extent of tumour budding (P = 0.014). There was no association between extent of budding and cytoplasmic pseudo-fragments (P = 0.12). Conclusions: Cytoplasmic pseudo-fragments may be a marker for an activated budding phenotype that is associated with cell motility and increased invasiveness in CRC and is independent of the extent of budding.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 21 条
[1]  
Adachi Y, 2001, INT J CANCER, V95, P290, DOI 10.1002/1097-0215(20010920)95:5<290::AID-IJC1050>3.0.CO
[2]  
2-I
[3]   Prognostic significance of laminin-5 γ2 chain expression in colorectal carcinoma -: Immunohistochemical analysis of 103 cases [J].
Aoki, S ;
Nakanishi, Y ;
Akimoto, S ;
Moriya, Y ;
Yoshimura, K ;
Kitajima, M ;
Sakamoto, M ;
Hirohashi, S .
DISEASES OF THE COLON & RECTUM, 2002, 45 (11) :1520-1527
[4]   Nuclear overexpression of the oncoprotein β-catenin in colorectal cancer is localized predominantly at the invasion front [J].
Brabletz, T ;
Jung, A ;
Hermann, K ;
Gunther, K ;
Hohenberger, W ;
Kirchner, T .
PATHOLOGY RESEARCH AND PRACTICE, 1998, 194 (10) :701-704
[5]   Nr-CAM is a target gene of the β-catenin/LEF-1 in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis [J].
Conacci-Sorrell, ME ;
Ben-Yedidia, T ;
Shtutman, M ;
Feinstein, E ;
Einat, P ;
Ben-Ze'ev, A .
GENES & DEVELOPMENT, 2002, 16 (16) :2058-2072
[6]   PROGNOSTIC VALUE OF TUMOR BUDDING IN PATIENTS WITH COLORECTAL-CANCER [J].
HASE, K ;
SHATNEY, C ;
JOHNSON, D ;
TROLLOPE, M ;
VIERRA, M .
DISEASES OF THE COLON & RECTUM, 1993, 36 (07) :627-635
[7]  
Hlubek F, 2001, CANCER RES, V61, P8089
[8]   Assessment df invasive growth pattern and lymphocytic infiltration in colorectal cancer [J].
Jass, JR ;
Ajioka, Y ;
Allen, JP ;
Chan, YF ;
Cohen, RJ ;
Nixon, JM ;
Radojkovic, M ;
Restall, AP ;
Stables, SR ;
Zwi, LJ .
HISTOPATHOLOGY, 1996, 28 (06) :543-548
[9]   APC mutation and tumour budding in colorectal cancer [J].
Jass, JR ;
Barker, M ;
Fraser, L ;
Walsh, MD ;
Whitehall, VLJ ;
Gabrielli, B ;
Young, J ;
Leggett, BA .
JOURNAL OF CLINICAL PATHOLOGY, 2003, 56 (01) :69-73
[10]  
Jass JR, 1989, WHO INT HISTOLOGICAL